75
Views
13
CrossRef citations to date
0
Altmetric
Review

Clinical usefulness of 18F-FDG PET/CT for the detection of distant metastases in patients with non-small cell lung cancer at initial staging: a meta-analysis

, , , , &
Pages 1859-1864 | Published online: 04 Jul 2018

References

  • PostmusPEKerrKMOudkerkMESMO Guidelines CommitteeEarly and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201728suppl_4iv1iv2128881918
  • FerlayJAutierPBoniolMHeanueMColombetMBoylePEstimates of the cancer incidence and mortality in Europe in 2006Ann Oncol200718358159217287242
  • XuGZhaoLHeZPerformance of whole-body PET/CT for the detection of distant malignancies in various cancers: a systematic review and meta-analysisJ Nucl Med201253121847185423073605
  • AntochGStattausJNematATNon-small cell lung cancer: dual-modality PET/CT in preoperative stagingRadiology2003229252653314512512
  • CerfolioRJOjhaBBryantASRaghuveerVMountzJMBartolucciAAThe accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancerAnn Thorac Surg200478310171023 discussion 1017–102315337041
  • OhnoYKoyamaHOnishiYNon-small cell lung cancer: whole-body MR examination for M-stage assessment – utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CTRadiology2008248264365418539889
  • YiCAShinKMLeeKSNon-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imagingRadiology2008248263264218552311
  • PlathowCAschoffPLichyMPPositron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer – initial resultsInvest Radiol200843529029718424949
  • LeeHYLeeKSKimBTDiagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinomaJ Korean Med Sci20092461132113819949671
  • OpokaLKunikowskaJPodgajnyZStaging of non-small cell lung cancer using CT and integrated PET-CTPneumonol Alergol Pol201381151523258466
  • WhitingPFRutjesAWWestwoodMEQUADAS-2 GroupQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studiesAnn Intern Med2011155852953622007046
  • ChuHColeSRBivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approachJ Clin Epidemiol2006591213311332 author reply 1332–133317098577
  • ReitsmaJBGlasASRutjesAWScholtenRJBossuytPMZwindermanAHBivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviewsJ Clin Epidemiol2005581098299016168343
  • JaeschkeRGuyattGHSackettDLUsers’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working GroupJAMA199427197037078309035
  • OhnoYKoyamaHYoshikawaTThree-way comparison of whole-body MR, coregistered whole-body FDG PET/MR, and integrated whole-body FDG PET/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patientsRadiology2015275384986125584709
  • HuellnerMWde Galiza BarbosaFHusmannLTNM staging of non-small cell lung cancer: comparison of PET/MR and PET/CTJ Nucl Med2016571212626471696
  • LeeSMGooJMParkCMPreoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CTEur Radiol201626113850385726883332
  • WalterSDProperties of the summary receiver operating characteristic (SROC) curve for diagnostic test dataStat Med20022191237125612111876
  • RosmanASKorstenMAApplication of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testingAdv Med Sci200752768218217394